Barchart on MSN
Is Viatris Stock Underperforming the Nasdaq?
With a market cap of $11.3 billion, Viatris Inc. (VTRS) is a global pharmaceutical company headquartered in Pennsylvania with ...
Viatris faces declining sales and debt concerns, but a 2026 recovery may boost earnings. Read about the key risks and future ...
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Viatris Inc. is one of them. Viatris Inc. (NASDAQ:VTRS), formed from the 2020 merger of Mylan ...
Investing.com -- Deutsche Bank struck a more upbeat tone on European pharmaceuticals, upgrading Alvotech to Buy from Hold while keeping its price target at $14. Shares in Alvotech rose 4.6% in U.S.
Over the past seven trading days, VTRS shed around 9%, with daily losses including a 3.61% drop on September 15 and a 2.06% slide on September 12. The stock had been under steady pressure amid broader ...
J.P. Morgan analyst maintained a Hold rating on Viatris today and set a price target of $14.00. The company’s shares closed yesterday at $9.60. Take advantage of TipRanks Premium at 50% off! Unlock ...
In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Viatris Inc. is one of them. Viatris ...
If you give manufacturing a zero value and push all the debt onto commercial pharma, Aspen’s 8.5x multiple is half that of the average major generics group.
In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Mizuho health care sector strategist Jared Holz made an appearance on CNBC’s “The Exchange” on July 21 to ...
Zacks Investment Research on MSN
Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Theravance Biopharma (TBPH). Shares have added about 9.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will ...
Tega share price dropped as much as 4% in Mumbai on Thursday, the most in about a month, after announcing the deal that’s almost as big as the company’s market value.
Chicago, IL – September 4, 2025 – Today, Zacks Investment Ideas feature highlights Church & Dwight CHD, Eli Lilly LLY and Viatris VTRS. Investors closely monitor insider buys, as they can give hints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results